News Precipio, Inc.

Stocks

PRPO

US74019L6020

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 16:00:00 2026-08-28 EDT			5-day change	1st Jan Change
28.85 ^USD	-1.50%		-5.25%	+25.54%

08-17	Precipio, Inc., Q2 2026 Earnings Call, Aug 17, 2026
08-14	Precipio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

All News

Mentions Relevance

08-17	Precipio, Inc., Q2 2026 Earnings Call, Aug 17, 2026
08-14	Precipio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-14	Precipio Announces Q2-2026 Financial Results	AQ
07-31	Precipio Announces Q2-2026 Shareholder Update Call	AQ
06-29	Precipio, Inc.(NasdaqCM:PRPO) added to Russell 3000E Index	CI
06-29	Precipio, Inc.(NasdaqCM:PRPO) added to Russell Microcap Index	CI
06-29	Precipio, Inc.(NasdaqCM:PRPO) added to Russell 3000E Growth Benchmark	CI
06-28	Precipio, Inc.(NasdaqCM:PRPO) added to Russell Microcap Growth Benchmark Index	CI
06-12	Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting	AQ
06-11	Precipio to Present at the Planet MicroCap Las Vegas	AQ
05-18	Precipio, Inc., Q1 2026 Earnings Call, May 18, 2026
05-14	Precipio Announces Q1 2026 Financial Results	AQ
05-14	Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-13	Management team’s 2025 market-based Options have vested	AQ
05-06	Precipio Announces Q1-2026 Shareholder Update Call	AQ
04-02	Precipio, Inc., Q4 2025 Earnings Call, Apr 02, 2026
03-30	Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-29	Precipio, Inc. Auditor Raises 'Going Concern' Doubt	CI
03-12	Precipio Announces Q4 and year-end 2025 Shareholder Update Call	AQ
03-10	Precipio Inc Announces Bloodhound BCR::ABL1 Assay For Chronic Myeloid Leukemia	CI
03-10	Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay	AQ
02-25	Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year	AQ
01-15	Precipio Takes Major Steps Toward a Clean Balance Sheet	AQ
12-05	Precipio, Inc. to Showcase Its BCR::ABL1 Panel At 2025 Ash (American Society of Hematology) Meeting	CI
12-05	Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting	AQ